Related Experiment Video
Updated: Jun 24, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
The adipocyte IKK/NFkappaB pathway: a therapeutic target for insulin resistance
1University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Department of Physiology and Biophysics, 683 Hoes Lane West, Piscataway, NJ 08854, USA. ruanho@umdnj.edu
Abstract:
Insulin suppresses the release of non-esterified fatty acids from adipocytes and suppresses glucose production from hepatocytes, but stimulates glucose uptake by skeletal muscle, liver and adipose tissue. Insulin resistance, the failure of an ample supply of insulin to mediate these effects, is an early and fundamental defect in type 2 diabetes (T2D) associated with obesity. Adipose tissue not only acts as an energy depot, but also secretes a variety of endocrine, paracrine and autocrine factors, which regulate energy metabolism and insulin activity. In addition, adipose tissue from obese individuals has a distinct secretory profile that alters both adipocyte function and overall in vivo insulin sensitivity. Obesity is coupled to insulin resistance and diabetes through the action of adipose-derived factors, in a process that involves intricate signaling pathways and transcriptional regulators in various cell types of adipose tissue, in addition to cross-talk between adipose and non-adipose tissues. Thus, the dissection of the specific pathways that contribute to insulin resistance in obese individuals is a crucial component in understanding obesity-linked T2D. In this review, recent in vitro and in vivo data that implicate the IKK (inhibitor of kappaB kinase)/NFkappaB pathway, a component of both fatty acid and inflammatory cytokine signaling cascades, in the regulation of insulin sensitivity are discussed, and the value of this pathway as a therapeutic target in T2D is evaluated.
Insights
Insulin resistance, a key factor in type 2 diabetes (T2D), is linked to obesity. The inhibitor of kappaB kinase (IKK)/NFkappaB pathway in adipose tissue plays a role in this insulin resistance, offering a potential therapeutic target.
Area of Science:
- Metabolic diseases
- Endocrinology
- Molecular biology
Background:
- Insulin resistance is a fundamental defect in type 2 diabetes (T2D), particularly when associated with obesity.
- Adipose tissue, beyond energy storage, secretes factors influencing energy metabolism and insulin sensitivity.
- Obese adipose tissue exhibits altered secretory profiles, impacting adipocyte function and systemic insulin sensitivity.
Purpose of the Study:
- To review recent data on pathways contributing to insulin resistance in obesity.
- To evaluate the role of the inhibitor of kappaB kinase (IKK)/NFkappaB pathway in insulin sensitivity.
- To assess the therapeutic potential of targeting the IKK/NFkappaB pathway in T2D.
Main Methods:
- Review of in vitro and in vivo studies.
- Analysis of signaling pathways and transcriptional regulators.
- Examination of cross-talk between adipose and non-adipose tissues.
Main Results:
- The IKK/NFkappaB pathway is implicated in regulating insulin sensitivity.
- This pathway is involved in both fatty acid and inflammatory cytokine signaling cascades.
- Obesity-associated insulin resistance involves complex signaling in adipose tissue.
Conclusions:
- The IKK/NFkappaB pathway is a significant factor in obesity-linked insulin resistance.
- Targeting the IKK/NFkappaB pathway presents a potential therapeutic strategy for T2D.
- Understanding adipose-derived factors and their signaling is crucial for T2D research.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
PI3K/mTOR/AKT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
cAMP-dependent Protein Kinase Pathways
Type II Diabetes II: Pathophysiology
Cell Specific Gene Expression
